Clinical Utility and Measurement of Procalcitonin

Overview

Journal Clin Biochem Rev

Specialty Biochemistry

Date 2018 Jan 16

PMID 29332972

Citations 83

Authors

Intan Samsudin

Samuel D Vasikaran

Affiliations

Soon will be listed here.

Abstract

Procalcitonin (PCT), regarded as a biomarker specific for bacterial infections, is used in a variety of clinical settings including primary care, emergency department and intensive care. PCT measurement aids in the diagnosis of sepsis and to guide and monitor antibiotic therapy. This article gives a brief overview of PCT and its use in guiding antibiotic therapy in various clinical settings, as well as its limitations. PCT performance in comparison with other biomarkers of infection in particular CRP is also reviewed. Owing to its greater availability, CRP has been widely used as a biomarker of infection and sepsis. PCT is often reported to be more superior to CRP, being more specific for sepsis and bacterial infection. PCT starts to rise earlier and returns to normal concentration more rapidly than CRP, allowing for an earlier diagnosis and better monitoring of disease progression.

Citing Articles

A Panel of Diverse Inflammatory Biomarkers Is Not Associated with BMI-Calibrated Obesity nor with Dyslipidemia or Dysglycemia in Clinically Healthy Adults Aged 20 to 40 Years.

Sater M, Malalla Z, Ali M, Giha H Int J Environ Res Public Health. 2025; 22(2).

PMID: 40003433 PMC: 11855404. DOI: 10.3390/ijerph22020207.

Procalcitonin and presepsin for detecting bacterial infection and spontaneous bacterial peritonitis in cirrhosis: A systematic review and meta-analysis.

Wejnaruemarn S, Susantitaphong P, Komolmit P, Treeprasertsuk S, Thanapirom K World J Gastroenterol. 2025; 31(6):99506.

PMID: 39958447 PMC: 11752710. DOI: 10.3748/wjg.v31.i6.99506.

The standardization and efficacy of fermented (L.) in combination with enrofloxacin against artificially induced pneumonic pasteurellosis in rat models.

Prakoso Y, Susilo A, Widyarini S Open Vet J. 2025; 14(12):3404-3416.

PMID: 39927353 PMC: 11799618. DOI: 10.5455/OVJ.2024.v14.i12.25.

Infective Complications of Endobronchial Ultrasound-Transbronchial Needle Aspiration (EBUS-TBNA) and Clinical Biomarkers: A Concise Review.

Bosgana P, Ampazis D, Vlachakos V, Tzouvelekis A, Sampsonas F Diagnostics (Basel). 2025; 15(2).

PMID: 39857029 PMC: 11764001. DOI: 10.3390/diagnostics15020145.

Prognostic indicators and outcome in patients with acute liver failure, sepsis and with and without shock: a retrospective cohort study.

Wang D, Wang X, Mu J, Kuang Z, Zhang J, Lu X Ann Med. 2024; 57(1):2438833.

PMID: 39661398 PMC: 11636143. DOI: 10.1080/07853890.2024.2438833.

References

Oliveira C, Botoni F, Oliveira C, Silva C, Pereira H, Serufo J . Procalcitonin versus C-reactive protein for guiding antibiotic therapy in sepsis: a randomized trial. Crit Care Med. 2013; 41(10):2336-43. DOI: 10.1097/CCM.0b013e31828e969f. View

Hogarth M, Gallimore R, Savage P, Palmer A, Starr J, Bulpitt C . Acute phase proteins, C-reactive protein and serum amyloid A protein, as prognostic markers in the elderly inpatient. Age Ageing. 1997; 26(2):153-8. DOI: 10.1093/ageing/26.2.153. View

Dipalo M, Guido L, Micca G, Pittalis S, Locatelli M, Motta A . Multicenter comparison of automated procalcitonin immunoassays. Pract Lab Med. 2017; 2:22-28. PMC: 5597721. DOI: 10.1016/j.plabm.2015.07.001. View

Bafadhel M, Clark T, Reid C, Medina M, Batham S, Barer M . Procalcitonin and C-reactive protein in hospitalized adult patients with community-acquired pneumonia or exacerbation of asthma or COPD. Chest. 2010; 139(6):1410-1418. PMC: 3109646. DOI: 10.1378/chest.10-1747. View

Gerard Y, Hober D, Petitjean S, Assicot M, Bohuon C, Mouton Y . High serum procalcitonin level in a 4-year-old liver transplant recipient with a disseminated candidiasis. Infection. 1995; 23(5):310-1. DOI: 10.1007/BF01716295. View

Meisner , Tschaikowsky , Palmaers , Schmidt . Comparison of procalcitonin (PCT) and C-reactive protein (CRP) plasma concentrations at different SOFA scores during the course of sepsis and MODS. Crit Care. 2000; 3(1):45-50. PMC: 29013. DOI: 10.1186/cc306. View

Jensen J, Hein L, Lundgren B, Bestle M, Mohr T, Andersen M . Procalcitonin-guided interventions against infections to increase early appropriate antibiotics and improve survival in the intensive care unit: a randomized trial. Crit Care Med. 2011; 39(9):2048-58. DOI: 10.1097/CCM.0b013e31821e8791. View

Meisner M . Update on procalcitonin measurements. Ann Lab Med. 2014; 34(4):263-73. PMC: 4071182. DOI: 10.3343/alm.2014.34.4.263. View

Eberhard O, Langefeld I, Kuse E, Brunkhorst F, Kliem V, Schlitt H . Procalcitonin in the early phase after renal transplantation--will it add to diagnostic accuracy?. Clin Transplant. 1998; 12(3):206-11. View

10.

Meisner M, Tschaikowsky K, Hutzler A, Schick C, Schuttler J . Postoperative plasma concentrations of procalcitonin after different types of surgery. Intensive Care Med. 1998; 24(7):680-4. DOI: 10.1007/s001340050644. View

11.

Hensel M, Volk T, Docke W, Kern F, Tschirna D, Egerer K . Hyperprocalcitonemia in patients with noninfectious SIRS and pulmonary dysfunction associated with cardiopulmonary bypass. Anesthesiology. 1998; 89(1):93-104. DOI: 10.1097/00000542-199807000-00016. View

12.

Davis T, Assicot M, Bohuon C, St John A, Li G, Anh T . Serum procalcitonin concentrations in acute malaria. Trans R Soc Trop Med Hyg. 1994; 88(6):670-1. DOI: 10.1016/0035-9203(94)90221-6. View

13.

Papi A, Bellettato C, Braccioni F, Romagnoli M, Casolari P, Caramori G . Infections and airway inflammation in chronic obstructive pulmonary disease severe exacerbations. Am J Respir Crit Care Med. 2006; 173(10):1114-21. DOI: 10.1164/rccm.200506-859OC. View

14.

Rothberg M, Pekow P, Lahti M, Brody O, Skiest D, Lindenauer P . Antibiotic therapy and treatment failure in patients hospitalized for acute exacerbations of chronic obstructive pulmonary disease. JAMA. 2010; 303(20):2035-42. DOI: 10.1001/jama.2010.672. View

15.

Level C, Chauveau P, Delmas Y, Lasseur C, Pelle G, Peuchant E . Procalcitonin: a new marker of inflammation in haemodialysis patients?. Nephrol Dial Transplant. 2001; 16(5):980-6. DOI: 10.1093/ndt/16.5.980. View

16.

Bloos F, Trips E, Nierhaus A, Briegel J, Heyland D, Jaschinski U . Effect of Sodium Selenite Administration and Procalcitonin-Guided Therapy on Mortality in Patients With Severe Sepsis or Septic Shock: A Randomized Clinical Trial. JAMA Intern Med. 2016; 176(9):1266-76. DOI: 10.1001/jamainternmed.2016.2514. View

17.

Meynaar I, Droog W, Batstra M, Vreede R, Herbrink P . In Critically Ill Patients, Serum Procalcitonin Is More Useful in Differentiating between Sepsis and SIRS than CRP, Il-6, or LBP. Crit Care Res Pract. 2011; 2011:594645. PMC: 3113363. DOI: 10.1155/2011/594645. View

18.

Cuquemelle E, Soulis F, Villers D, Roche-Campo F, Ara Somohano C, Fartoukh M . Can procalcitonin help identify associated bacterial infection in patients with severe influenza pneumonia? A multicentre study. Intensive Care Med. 2011; 37(5):796-800. PMC: 7080069. DOI: 10.1007/s00134-011-2189-1. View

19.

Snider Jr R, Nylen E, Becker K . Procalcitonin and its component peptides in systemic inflammation: immunochemical characterization. J Investig Med. 1998; 45(9):552-60. View

20.

Bouadma L, Luyt C, Tubach F, Cracco C, Alvarez A, Schwebel C . Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial. Lancet. 2010; 375(9713):463-74. DOI: 10.1016/S0140-6736(09)61879-1. View